UNICREDIT BANK/PUT/ELI LILLY & CO/600/0.1/15.01.25 Share Price

Warrant

DE000HC96HC5

Real-time BOERSE MUENCHEN 07:01:30 21/06/2024 BST
0.65 EUR 0.00% Intraday chart for UNICREDIT BANK/PUT/ELI LILLY & CO/600/0.1/15.01.25
Current month-41.44%
1 month-54.55%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
21/06/24 0.65 0.00%
20/06/24 0.65 +10.17%
19/06/24 0.59 0.00%
18/06/24 0.59 -6.35%
17/06/24 0.63 -3.08%

Real-time BOERSE MUENCHEN

Last update June 21, 2024 at 07:01 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer UniCredit UniCredit
WKN HC96HC
ISINDE000HC96HC5
Date issued 11/09/2023
Strike 600 $
Maturity 15/01/2025 (209 Days)
Parity 10 : 1
Emission price 6.87
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 10.11
Lowest since issue 0.59
Delta-0.06x
Omega 7.305
Premium33.01x
Gearing132.39x
Moneyness 0.6774
Difference Strike -286 $
Difference Strike %-47.67%
Spread 0.23
Spread %31.08%
Theoretical value 0.6150
Implied Volatility 37.61 %
Total Loss Probability 90.80 %
Intrinsic value 0.000000
Present value 0.6150
Break even 593.42 €
Theta-0.04x
Vega0.07x
Rho-0.02x

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
886 USD
Average target price
855.4 USD
Spread / Average Target
-3.45%
Consensus